ArticleBMC cancer2020

The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial.

Takuma Higurashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.